Education
About Us
Working with TipRanks
Follow Us
Biomarin Pharmaceutical Inc. (DE:BM8)
:BM8
RESEARCH TOOLSreports
BioMarin Pharmaceutical (BM8) Ownership Overview
0.97% Insiders
35.19%
Mutual Funds
40.19% Other Institutional Investors
21.06% ETFs
2.60% Public Companies and
Individual Investors
The ownership structure of BioMarin Pharmaceutical (DE:BM8) stock is a mix of institutional, retail, and individual investors. Approximately 96.44% of the company’s stock is owned by Institutional Investors, 0.97% is owned by Insiders, and 2.60% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 07, 2025 | xxxxxxxxxxxxx | $501313 | |
Nov 14, 2024 | xxxxxxxxxxxxx | $350301 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $1380 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $659929 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $771275 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $917985 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 17,773,281 | Institution | 9.27% | 1,028,130,986 | |
| 16,873,529 | Institution | 8.80% | 976,083,032 | |
| 15,760,524 | Institution | 8.22% | 911,699,032 | |
| 14,955,240 | Institution | 7.80% | 865,115,768 | |
| 13,816,614 | Institution | 7.20% | 799,249,670 | |
| 11,525,325 | Institution | 6.01% | 666,705,475 | |
| 10,800,059 | Institution | 5.63% | 624,751,013 | |
| 8,285,924 | Institution | 4.32% | 479,315,846 | |
| 7,165,088 | Institution | 3.74% | 414,478,846 | |
| 5,887,732 | Institution | 3.07% | 340,587,633 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 16,873,529 | Institution | 8.80% | 976,083,032 | |
| 11,525,325 | Institution | 6.01% | 666,705,475 | |
| 8,285,924 | Institution | 4.32% | 479,315,846 | |
| 7,165,088 | Institution | 3.74% | 414,478,846 | |
| 5,887,732 | Institution | 3.07% | 340,587,633 | |
| 3,099,926 | Institution | 1.62% | 179,321,419 | |
| 1,887,413 | Institution | 0.98% | 109,181,180 | |
| 1,863,184 | Institution | 0.97% | 107,779,605 | |
| 788,707 | Institution | 0.41% | 45,624,334 | |
| 763,789 | Institution | 0.40% | 44,182,902 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Biomarin Pharmaceutical Inc. (DE:BM8)?
According to the latest TipRanks data, approximately 40.19% of the company's stock is held by institutional investors, 0.97% is held by insiders, and 2.60% is held by retail investors.
What percentage of Biomarin Pharmaceutical Inc. (DE:BM8) stock is held by institutional investors?
According to the latest TipRanks data, approximately 40.19% of Biomarin Pharmaceutical Inc. (DE:BM8) stock is held by institutional investors.
What percentage of Biomarin Pharmaceutical Inc. (DE:BM8) stock is held by retail investors?
According to the latest TipRanks data, approximately 2.60% of Biomarin Pharmaceutical Inc. (DE:BM8) stock is held by retail investors.
Who owns the most shares of Biomarin Pharmaceutical Inc. (DE:BM8)?
Theofanis Kolokotrones owns the most shares of Biomarin Pharmaceutical Inc. (DE:BM8).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.